Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,626 | -72,700 | -135,352 | -108,501 | -73,958 |
| Depreciation Amortization | 8,356 | 8,121 | 6,222 | 3,745 | 2,132 |
| Accounts receivable | -7,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -13,708 | 6,252 | 5,758 | -744 | -706 |
| Other Working Capital | -9,189 | 91,397 | 72,466 | -2,134 | 6,286 |
| Other Operating Activity | 37,369 | 8,926 | 7,104 | 15,168 | 6,883 |
| Operating Cash Flow | $-22,798 | $41,996 | $-43,802 | $-92,466 | $-59,363 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -97,133 | -40,464 | 107,780 | -206,417 | N/A |
| PPE Investments | -4,700 | -3,988 | -18,979 | -12,802 | -9,653 |
| Investing Cash Flow | $-101,833 | $-44,452 | $88,801 | $-219,219 | $-9,653 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30,708 | 52,532 | 27,030 | 20,494 | 237,899 |
| Other Financing Activity | -357 | 46,360 | 462 | -28 | 139,663 |
| Financing Cash Flow | $30,351 | $98,892 | $27,492 | $20,466 | $377,562 |
| Beginning Cash Position | 229,117 | 132,681 | 60,190 | 351,409 | 42,863 |
| End Cash Position | 134,837 | 229,117 | 132,681 | 60,190 | 351,409 |
| Net Cash Flow | $-94,280 | $96,436 | $72,491 | $-291,219 | $308,546 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,798 | 41,996 | -43,802 | -92,466 | -59,363 |
| Capital Expenditure | -4,700 | -3,988 | -19,041 | -12,911 | -9,732 |
| Free Cash Flow | -27,498 | 38,008 | -62,843 | -105,377 | -69,095 |